You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 22, 2024

Details for Patent: 6,291,488


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,291,488
Title: Preventing protozoal infections
Abstract:The invention relates to combinations of atovaquone and proguanil, their use in the treatment and prophylaxis of parasitic infections such as protozoal parasitic infections, e.g., malaria and toxoplasmosis, and infections caused by P. carinii and their use in the manufacture of medicaments for the treatment and/or prophylaxis of such infections. The combinations can conveniently be administered in a single pharmaceutical formulation. Preferably, atovaquone and proguanil are administered in a potentiating ratio so that they act in synergy.
Inventor(s): Gutteridge; Winston Edward (Beckenham, GB), Hutchinson; David Brian Ashton (Beckenham, GB), Latter; Victoria Susan (Beckenham, GB), Pudney; Mary (Beckenham, GB)
Assignee: Glaxo Wellcome Inc. (Research Triangle Park, NC)
Application Number:09/678,485
Patent Claim Types:
see list of patent claims
Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,291,488: A Detailed Analysis

Introduction

Patent 6,291,488, granted in 2001, is a significant example of how patent claims and scope have been evaluated and interpreted under U.S. patent law. This analysis will delve into the key aspects of the patent, including its claims, the patent landscape, and the implications of recent legal and regulatory updates.

Background of the Patent

United States Patent 6,291,488, titled "Method and system for automatic generation of a directory of frequently used links," was granted on September 18, 2001. This patent pertains to a method and system designed to automate the generation of a directory of frequently used links, typically in the context of web browsing.

Claims Analysis

Claim Structure and Eligibility

The claims of Patent 6,291,488 need to be analyzed in the context of 35 U.S.C. § 101, which governs patent eligibility. Recent updates, such as the 2024 USPTO guidance on AI patent eligibility, emphasize the importance of integrating judicial exceptions into practical applications to ensure patent eligibility[1].

  • Abstract Ideas and Practical Applications: Claims that merely describe abstract ideas without specifying how the result is achieved are often deemed ineligible under § 101. For example, if a claim in Patent 6,291,488 simply states the generation of a directory without detailing the method or process, it might be considered result-oriented and thus ineligible[2].
  • Inventive Concept: To be patent-eligible, claims must include an inventive concept that transforms the abstract idea into a concrete invention. This involves specifying the method or process in a way that adds a meaningful limit and integrates the judicial exception into a practical application[1].

Example Claims

  • Claim 1: If the patent claims a method for generating a directory of frequently used links without specifying how the links are identified or ranked, it might be considered too abstract and ineligible.
  • Claim 2: However, if the claim details the specific steps involved, such as using user behavior data and machine learning algorithms to rank and categorize links, it would likely be considered patent-eligible due to the practical application and inventive concept[1].

Patent Landscape Analysis

Technological Domain

Patent landscape analysis helps in understanding the broader technological domain in which Patent 6,291,488 resides. This includes:

  • Competitor Analysis: Identifying other patents and patent applications in the same technological domain can reveal market trends, competitor strategies, and potential areas for innovation.
  • Legal Status: Understanding the legal status (alive, pending, lapsed, revoked, or expired) of related patents is crucial for strategic decision-making[5].

Market Developments

  • Mergers and Acquisitions: Analyzing mergers and acquisitions in the industry can indicate how technologies are being consolidated and where future innovations might be focused.
  • Licensing and Litigation: Tracking licensing agreements and litigation activities related to similar patents can provide insights into the commercial viability and legal robustness of the technology[5].

Recent Legal and Regulatory Updates

USPTO Guidance on AI Patents

The 2024 USPTO guidance update on AI patents is particularly relevant. This update clarifies that the method of invention development, including the use of AI, does not impact subject matter eligibility. Instead, the focus remains on the claimed invention itself, ensuring that AI-assisted inventions are evaluated on equal footing with other technologies[1].

Result-Oriented Claims

Recent cases, such as Interval Licensing LLC v. AOL Inc. and American Axle & Manufacturing v. Neapco Holdings LLC, reinforce the principle that claims directed to a result without detailing the method or process are ineligible under § 101. This emphasizes the need for specific, inventive methods in patent claims[2].

Practical Applications and Technological Improvements

To ensure patent eligibility, claims must demonstrate real-world applications that provide concrete benefits or solve specific problems in the relevant field. For example:

  • Improved User Experience: If the method for generating a directory of frequently used links includes steps that enhance user experience, such as personalized recommendations or real-time updates, it would be considered a practical application that transforms the abstract idea into patent-eligible subject matter[1].

Key Takeaways

  • Specificity in Claims: Patent claims must be specific and detail the method or process to achieve the desired result to avoid being deemed result-oriented and ineligible.
  • Practical Applications: Claims must integrate judicial exceptions into practical applications to ensure patent eligibility.
  • Inventive Concept: An inventive concept is necessary to transform abstract ideas into concrete inventions.
  • Patent Landscape Analysis: Understanding the broader patent landscape is crucial for strategic decision-making and identifying opportunities for innovation.

FAQs

What is the significance of the 2024 USPTO guidance update on AI patents?

The 2024 USPTO guidance update clarifies that the use of AI in the method of invention development does not impact subject matter eligibility, ensuring AI-assisted inventions are evaluated on equal footing with other technologies[1].

Why are result-oriented claims often deemed ineligible under § 101?

Result-oriented claims are often deemed ineligible because they do not specify the method or process for achieving the desired result, failing to provide an inventive concept that transforms the abstract idea into a concrete invention[2].

How does patent landscape analysis benefit businesses?

Patent landscape analysis provides valuable insights into competitors, market trends, and potential areas for innovation, helping businesses make informed strategic decisions[5].

What is the importance of specifying practical applications in patent claims?

Specifying practical applications in patent claims is crucial as it demonstrates how the abstract idea is applied in a way that provides concrete benefits or solves specific problems, ensuring patent eligibility[1].

Can AI-assisted inventions be patented under the current USPTO guidance?

Yes, AI-assisted inventions can be patented if the claimed invention itself meets the criteria for patent eligibility, regardless of the use of AI in the development process[1].

Sources

  1. Mintz: "Understanding the 2024 USPTO Guidance Update on AI Patent Eligibility"
  2. Vklaw: "Patently Unclear: Why Result-Oriented Claims Don't Make the Cut Under 35 U.S.C. § 101"
  3. USPTO: "Patent Claims Research Dataset"
  4. Spencer Fane: "The Federal Circuit Breathes New Life into False Patent Marking Claims via Section 43(a) of the Lanham Act"
  5. Sagacious Research: "Navigating Technological Domains with Patent Landscape Analysis"

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,291,488

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Foreign Priority and PCT Information for Patent: 6,291,488

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
United Kingdom9224739Nov 26, 1992

International Family Members for US Patent 6,291,488

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 517 ⤷  Subscribe
African Regional IP Organization (ARIPO) 9300592 ⤷  Subscribe
Austria 191340 ⤷  Subscribe
Australia 5532194 ⤷  Subscribe
Australia 5532294 ⤷  Subscribe
Australia 685408 ⤷  Subscribe
Bulgaria 62595 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.